JPAC Joint United Kingdom (UK) Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee

Latest Updates

This page lists all changes to DSG-WB 203 after Release 01.
The changes are listed with the most recent change at the top.

Changes introduced with Release 37

Hepatitis A - See Change Notification No. 04 - 2017
Central Nervous System Disease - See Change Nofication No.03 - 2017

Changes introduced with Release 36

Cardiac surgery clarification - See Change Notifcation No. 37 -2016

Changes introduced with Release 35

Blood Safety Entry and  Homosexual and Bisexual Indiviudals - See Change Nofication No. 36 - 2016

Changes introduced with Release 34

Tropical Viruses     See Change Notification No. 35 - 2016

Changes introduced with Release 33

Acne See Change Notification No. 18 - 2016
Disabled Donor See Change Notification No. 19 - 2016
High Haemoglobin See Change Notification No. 20 - 2016
Immunoglobulin See Change Notification No. 21 - 2016

 

Changes introduced with Release 32

Tropical Viruses       See Change Notification No. 014 - 2016
Viral Haemorrhagic Fever   See Change Notification No. 015 - 2016

 

Changes introduced with Release 31

Viral Haemorrhagic Fever                    See Change Notification No. 11 -2016
West Nile Virus                                     See Change Notification No. 09 - 2016

Tropical Viruses                                    See Change Notification No. 08 - 2016
Kidney and Bladder Disease Disease  See Change Notification No. 06 - 2016
Memorial Tattoos, Body Piercing          See Change Notification No. 05 - 2016
Appendix 2 Table of Immunizations      See Change Notification No. 04- 2016
Hepatitis E                                            See Change Notification No. 03 - 2016
Hepatitis A                                            See Change Notification No. 02 - 2016
Glycogen Storage Disease                   See Change Notification No. 01 - 2016

Changes introduced with Release 30 

Alopecia and Automimmune Disease See Change Notification No 25 - 2015
Chronic Fatigue Syndrome See Change Notification No 26 - 2015

Changes introduced with Release 29

Central Nervous System See Change Notification No 10 - 2015
Communication Difficulties See Change Notification No 11 - 2015
Complementary Therapy See Change Notification No 12 - 2015
Injectable Tanning Agents See Change Notification No 15 - 2015
   

The changes made with Change Notification No. 15 - 2015 to the Blood Safety Entry have also been made to the Blood and Tissue Safety Entry N.I.

Injectable Tanning Agents has been added to index and linked to Blood Safety Entry (England, Scotland and Wales)  
Cosmetic Fillers and Faecal Microbiota Transplantation have been added to index and linked to Complementary Therapy 

 

Changes introduced with Release 28

Asthma See Change Notification No 02 - 2015
Kidney and Bladder Disease See Change Notification No 03 - 2015
Malignancy See Change Notification No 04 - 2015
Nonsteroidal Anti-Inflammatory Drugs and Drug Index See Change Notification No 05 - 2015
   

Changes introduced with Release 27

Hepatitis of Unknown Cause See Change Notification No 44 - 2014
Tuberculosis See Change Notification No 45 - 2014
Mental Health Problems See Change Notification No 46 - 2014
Respiratory Disease See Change Notification No 47 - 2014
Thrombosis See Change Notification No 48 - 2014

Clarifications have been made to South American Trypanosomiasis, Eye Disease and Accept topics
Index Items have been added and linked as below:
Latent Tuberculosis to link to Accept
Retinal Vein Thrombosis to link to Thrombosis
Acoustic Neuroma – Surgery and Vestibular Schwannoma – Surgery to link to Neurosurgery
Acoustic Neuroma – Causing Vertigo and Vestibular Schwannoma – Causing Vertigo to link to Vertigo
Reversible Cerebral Vasoconstriction Syndrome and RCVS to link to Migraine
Brain Cyst, Arachnoid Cyst, Dermoid Cyst, Colloid Cyst and Epidermoid Cyst to link to Accept

Changes introduced with Release 26

Viral Haemorrhagic Fever Risk See Change Notification No. 43 – 2014
In Index Ebola Fever – Contact With has been re linked to Viral Haemorrhagic Fever

Changes introduced with Release 25

West Nile Virus See Change Notification No. 42 - 2014

Changes introduced with Release 24

Chikungunya Virus Risk See Change Notification No. 41 - 2014

Changes introduced with Release 23

Chikungunya Virus Risk See Change Notification No. 27 - 2014

Changes introduced with Release 22

Accept See Change Notification No. 18 - 2014
Autoimmune Disease See Change Notification No. 19 - 2014
Central Nervous System Disease See Change Notification No. 20 - 2014
Complementary Therapy See Change Notification No. 21 - 2014
Kidney and Bladder Disease See Change Notification No. 22 - 2014
Osteopenia See Change Notification No. 23 - 2014
Vitamins and Other Nutritional Supplements See Change Notification No. 24 - 2014
Chikungunya Virus See Change Notification No. 26 - 2014

The title of the topic Kidney Disease has been changed to Kidney and Bladder Disease, and a number of new index items have been added leading to Central Nervous System Disease, Pituitary Disorders, Kidney and Bladder Disease and Autoimmune Disease

Changes introduced with Release 21

Chikungunya Virus See Change Notification No. 01 - 2014

Changes introduced with Release 20

Malignancy See Change Notification No. 18 - 2013
Skin Disease and Dermatitis - Alitretinoin See Change Notification No. 20 - 2013
South American Trypanosomiasis See Change Notification No. 21 - 2013
Surgery See Change Notification No. 22 - 2013

Lichen Planus has been removed from the topic list and National Help Lines topic, Welcome and Preliminary pages have been updated.
Index items
Arnold – Chiari Malformation, Chiari Malformation and Syringomyelia have been added and linked to Neurosurgery, Budd Chiari Syndrome has been relinked from Neurosurgery to Surgery.
Autologous Platelet Rich Plasma has been added and linked to Transfusion.
Ductal Carcinoma in Situ, Lentigo Maligna, Lentigo Maligna Melanoma, Prostatic Intraepithelial Neoplasia, Tamoxifen – for Breast Malignancy Prophylaxis, Raloxifen - for Breast Malignancy Prophylaxis and Vulval Carcinoma in Situ have been added all linking to Malignancy.
Alitretinoin – for Skin Disease and Toctino® - for Skin Disease have been added and linked to Skin Disease.
Alitretinoin – for Dermatitis and Toctino® - for Dermatitis have been added and linked to Dermatitis.

Changes introduced with Release 19

West Nile Virus (WNV) See Change Notification No. 14 - 2013

Changes introduced with Release 18

Hepatitis B See Change Notification No. 02 - 2013
Infection Chronic SeeChange Notification No. 03 - 2013
Chest Pain See Change Notification No. 05 - 2013
Cardiovascular Disease See Change Notification No. 06 - 2013
Wounds, Mouth and Skin Ulcers See Change Notification No. 07 - 2013

Changes introduced with Release 17

West Nile Virus (WNV) See Change Notification No. 01 - 2013

Changes introduced with Release 16

Sickle-Cell Trait See Change Notification No. 27 - 2012
Kidney Disease See Change Notification No. 28 - 2012
Decompression Illness See Change Notification No. 29 - 2012

Index items for Decompression Illness, Decompression Sickness, the Bends and Caisson Disease have been added.

Changes introduced with Release 15

West Nile Virus (WNV) See Change Notification No. 25 - 2012
West Nile Virus (WNV) See Change Notification No. 26 - 2012

Changes introduced with Release 14

Malaria See Change Notification No. 20 - 2012
West Nile Virus See Change Notification No. 21 - 2012
Cupping/Wet Cupping See Change Notification No. 22 - 2012
Cardiovascular Disease See Change Notification No. 23 - 2012
Mobilised Granulocytes See Change Notification No. 24 - 2012

Index items for Cupping, Wet Cupping, Heart Murmur and Heart Valve Abnormality have been added

Changes introduced with Release 13

West Nile Virus (WNV) SeeChange Notification No. 19 - 2012

Changes introduced with Release 12

Acne See Change Notification No. 06 - 2012
Toxoplasmosis SeeChange Notification No. 07 - 2012
Psoriasis See Change Notification No. 08 - 2012
Pregnancy See Change Notification No. 09 - 2012
Dermatitis See Change Notification No. 10 - 2012
Skin Disease See Change Notification No. 11 - 2012
Cardiovascular Disease See Change Notification No. 12 - 2012
Cardiac Surgery See Change Notification No. 13 - 2012

Clarification has been made to the malignancy topic and additional index items for Fish pedicures, Lichen Planus, Acitretin - for Skin Disease, Neotigason - for Skin Disease, Tacrolimus - for Dermatitis, Tacrolimus - for Skin Disease, Protopic - for Dermatitis, Protopic - for Skin Disease, Pimecrolimus - for Dermatitis, Pimecrolimus - for Skin disease, Elide - for Dermatitis, Elide - for Skin Disease added.

Changes introduced with Release 11

West Nile Virus (WNV) See Change Notification No. 03 - 2012

Changes introduced with Release 10

Donor Weight See Change Notification No. 22 - 2011
Cardiovascular Disease See Change Notification No. 23 - 2011
Surgery See Change Notification No. 24 - 2011
XMRV See Change Notification No. 25 - 2011
Hepatitis C See Change Notification No. 26 - 2011

Changes introduced with Release 09

Blood Safety Entry See Change Notification No. 16 - 2011
Homosexual and Bisexual Individuals See Change Notification No. 17 - 2011
West Nile Virus (WNV) See Change Notification No. 19 - 2011

Changes introduced with Release 08

West Nile Virus (WNV) See Change Notification No. 18 - 2011

Changes introduced with Release 07

West Nile Virus (WNV) See Change Notification No. 15 - 2011

Changes introduced with Release 06

West Nile Virus (WNV) See Change Notification No. 11 - 2011

Changes introduced with Release 05

Pregnancy See Change Notification No. 01 - 2011
Trying to Conceive See Change Notification No. 02 - 2011
Immunization - Live See Change Notification No. 03 - 2011
Syphilis See Change Notification No. 04 - 2011
Porphyria See Change Notification No. 05 - 2011

Changes introduced with Release 04

Donor Weight and Donation Volumes See Change Notification No. 13 - 2010

Changes introduced with Release 03

Chronic Fatigue Syndrome See Change Notification No. 08 - 2010

Changes introduced with Release 02

West Nile Virus (WNV) See Change Notification No. 09 - 2010